Product Information
TINIDAZOLE 250 MG TABLET is a generic product labeled by Edenbridge Pharmaceuticals LLC, priced at $1.5032 per EA under NDC 42799020701. Its NADAC has been published 138 times since Feb 10, 2016.
FDA first approved this application on Aug 4, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
Edenbridge Pharmaceuticals LLCNDC
42799020701
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
TINIDAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA203808FDA Approved
8/4/2015
TE Code
AB
On Market Since
12/20/2019
Pharmacological Classes
Price Statistics
The NADAC for TINIDAZOLE 250 MG TABLET has been published 138 times since Feb 10, 2016, and over the history we have for it it has declined 36.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.5032 per EA |
|---|---|
| All-time high | $2.3575 (May 11, 2016) |
| All-time low | $1.2526 (Feb 18, 2026) |
| 52-week high | $1.5931 |
| 52-week low | $1.2526 |
| Median price | $1.4412 |
| Average price | $1.5376 |
| Largest weekly change | -39.9% (May 22, 2024) |
| Weeks tracked | 138 |
| Tracking since | Feb 10, 2016 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Edenbridge Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Tinidazole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nitroimidazole Antimicrobial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TINIDAZOLE 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TINIDAZOLE 250 MG TABLET, manufactured by Edenbridge Pharmaceuticals LLC, is $1.5032 per EA (NDC 42799020701), effective Sep 30, 2026.
How has the price of TINIDAZOLE 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for TINIDAZOLE 250 MG TABLET has declined 36.2%. It has been tracked across 138 weekly CMS publications since Feb 10, 2016.
What are the highest and lowest recorded NADAC prices for TINIDAZOLE 250 MG TABLET?
Since Feb 10, 2016, the NADAC for TINIDAZOLE 250 MG TABLET has ranged from a low of $1.2526 (Feb 18, 2026) to a high of $2.3575 (May 11, 2016), with a median of $1.4412 per EA.
Are there cheaper alternatives to TINIDAZOLE 250 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TINIDAZOLE 250 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures TINIDAZOLE 250 MG TABLET?
TINIDAZOLE 250 MG TABLET (NDC 42799020701) is labeled by Edenbridge Pharmaceuticals LLC, and CMS classifies it as a generic product.